InvestorsHub Logo
Followers 19
Posts 1039
Boards Moderated 0
Alias Born 04/18/2018

Re: None

Wednesday, 05/06/2020 2:27:59 PM

Wednesday, May 06, 2020 2:27:59 PM

Post# of 35961
In MedicNova's April 20,2020 press release the new patent application builds on an existing patent and names mipsagargin and other drugs as possible combination therapies for all types of glioblastoma. Ibudilast is already in a clinical trial and the new listed drugs could be incorporated in that trial. Although ibudilast has orphan drug status until 2039 it appears that MedicNova is moving fast to get this drug commercialized.